Could allergen-specific immunotherapy benefit from the use of nanocarriers?

Nanomedicine (Lond). 2016 Jun;11(11):1329-31. doi: 10.2217/nnm-2016-0111. Epub 2016 May 12.

Authors

Hannah Pohlit^{1

2

3}, Holger Frey², Joachim Saloga¹

Affiliations

¹ Department of Dermatology, University Medical Center Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.
² Institute of Organic Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany.
³ Graduate School Materials Science in Mainz, Staudinger Weg 9, 55128 Mainz, Germany.

PMID: 27221075
DOI: 10.2217/nnm-2016-0111

No abstract available

Keywords: AIT (allergen-specific immunotherapy); antigen delivery; drug delivery; nanomedicine; nanoparticles.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Allergens / administration & dosage
Desensitization, Immunologic / methods*
Drug Delivery Systems
Humans
Nanomedicine
Nanoparticles / administration & dosage

Substances

Allergens